On 27th June, Dr Victoria Savage, Chief Scientific Officer for Infex Therapeutics, has been invited to give a talk on the Global Antibiotic R&D Partnership (GARDP) REVIVE webinar.
Vicky will discuss how to progress antibacterial drug development programs in an SME, and the challenges that SMEs can face.
To register for the webinar, click here.
For more information about the webinar, click here.